New use of old drug reduces risk of kidney cancer returning
Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third, according to new research.
Jul 11, 2021
0
3
Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of cancer recurring by a third, according to new research.
Jul 11, 2021
0
3
In recent years, cancer immunotherapy has been effective in treating patients with immunogenic, or so-called "hot" tumors with increased levels of inflammation and the presence of immune cells in and around the tumors. Prostate ...
Jun 24, 2021
0
4
The immune nature of kidney cancer stands out when compared to other cancers: More immune cells infiltrate kidney cancers than most other solid tumors, and kidney cancer is one of the most responsive malignancies to today's ...
May 20, 2021
0
9
A new cancer vaccine could boost the positive effects of existing immunotherapy drugs, improving the success rate of treatments from 20% to 75% of cases, according to a new study by immunologists from the University of Konstanz. ...
May 18, 2021
0
218
Patients with one or more health conditions are more likely to be screened for colorectal cancer than those without comorbidities, according to new research in the Journal of Osteopathic Medicine. However, patients with five ...
May 3, 2021
0
3
A new study by researchers at the UCLA Jonsson Comprehensive Cancer Center found using percutaneous image guided needle based thermal ablation—the precise application of extreme heat or cold to a tumor using sophisticated ...
Mar 29, 2021
0
3
In the last two decades, immunotherapy has emerged as a leading treatment for advanced renal carcinoma cancer (more commonly known as kidney cancer). This therapy is now part of the standard of care, but it doesn't work for ...
Mar 11, 2021
0
59
The need for pediatric nephrologists to develop a special expertise in the onco-nephrology field is increasingly important as childhood cancer rates have been on the rise and new therapy protocols are advancing, according ...
Mar 3, 2021
0
3
Researchers from Kumamoto University (Japan) have clarified the mechanism by which blood and lymph vessels remain segregated from one another after development. The characteristics and structures of these two vessel types ...
Feb 5, 2021
0
4
A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial ...
Feb 3, 2021
0
1